HighTower Advisors
STJ

HighTower Advisors’s St Jude Medical STJ Stock Holding History

HighTower Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,737
Closed -$300K – 2224
2016
Q4 		$300K Buy
3,737
+59
+2% +$4.68K ﹤0.01% 1476
2016
Q3 		$295K Sell
3,678
-2,237
-38% -$181K ﹤0.01% 1462
2016
Q2 		$460K Sell
5,915
-33,186
-85% -$2.37M 0.01% 1165
2016
Q1 		$2.15M Sell
39,101
-659
-2% -$35.9K 0.01% 692
2015
Q4 		$2.46M Buy
39,760
+844
+2% +$53.2K 0.03% 556
2015
Q3 		$2.46M Buy
38,916
+3,758
+11% +$268K 0.03% 545
2015
Q2 		$2.57M Buy
+35,158
New +$2.54M 0.04% 469
2015
Q1 		– Sell
-29,317
Closed -$1.91M – 1734
2014
Q4 		$1.91M Buy
29,317
+10,047
+52% +$647K 0.03% 600
2014
Q3 		$1.16M Buy
+19,270
New +$1.26M 0.02% 727
2013
Q4 		– Sell
-24,247
Closed -$1.3M – 1645
2013
Q3 		$1.3M Sell
24,247
-19,694
-45% -$1.01M 0.03% 548
2013
Q2 		$2M Buy
+43,941
New +$1.9M 0.05% 396

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

HighTower Advisors's STJ Position: Q1 2017 in Review

HighTower Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,737 shares — an estimated $300K sold.

HighTower Advisors first reported a position in STJ in Q2 2013 and held it in 11 quarters. The position peaked at $2.57M in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • HighTower Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • HighTower Advisors sold 3,737 St Jude Medical shares in Q1 2017, an estimated $300K.
  • HighTower Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 11 quarters.
  • HighTower Advisors's St Jude Medical position peaked at $2.57M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on HighTower Advisors's 13F filing for Q1 2017, filed 16 May 2017.